Delivery Order SPE2DB20D1109-SPE2DB24FN45X
Award Date 1/19/24
Potential Completion Date 1/22/24
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,106.01 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Insulin Aspart 100 Unit/ML Pen 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $28,673.28 and a completion date of January 31, 2024. This delivery order is issued under a single award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025. The IDC serves as the...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,447.41 firm-fixed-price delivery order (SPE2DX15D3003|SPE2DX24F5Q4Z) to AmerisourceBergen Drug Corp's Corporate Office division for 4,565,844,165 units of Insulin Aspart 100 Unit/mL Pen 3mL. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563449313 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $3,329.97 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,240.20 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of insulin aspart 100 unit/ml pen 3ml to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31,...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,926.89, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...